日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Escherichia coli O45:K1 Glutathione-regulated potassium-efflux system ancillary protein KefG (kefG) CSB-YP483477EOK
CSB-EP483477EOK
CSB-BP483477EOK
CSB-MP483477EOK
CSB-EP483477EOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O45:K1 Thr operon leader peptide (thrL) CSB-YP483478EOK
CSB-EP483478EOK
CSB-BP483478EOK
CSB-MP483478EOK
CSB-EP483478EOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O45:K1 Transcriptional repressor NrdR (nrdR) CSB-YP483479EOK
CSB-EP483479EOK
CSB-BP483479EOK
CSB-MP483479EOK
CSB-EP483479EOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O45:K1 Trigger factor (tig) CSB-YP483480EOK
CSB-EP483480EOK
CSB-BP483480EOK
CSB-MP483480EOK
CSB-EP483480EOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O45:K1 Cobalamin synthase (cobS), partial CSB-YP483481EOK1
CSB-EP483481EOK1
CSB-BP483481EOK1
CSB-MP483481EOK1
CSB-EP483481EOK1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O45:K1 1- (5-phosphoribosyl)-5-[ (5-phosphoribosylamino)methylideneamino] imidazole-4-carboxamide isomerase CSB-YP483482EOK
CSB-EP483482EOK
CSB-BP483482EOK
CSB-MP483482EOK
CSB-EP483482EOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O45:K1 Rhomboid protease glpG (glpG), partial CSB-YP483483EOK1
CSB-EP483483EOK1
CSB-BP483483EOK1
CSB-MP483483EOK1
CSB-EP483483EOK1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O45:K1 Sulfurtransferase TusA (tusA) CSB-YP483484EOK
CSB-EP483484EOK
CSB-BP483484EOK
CSB-MP483484EOK
CSB-EP483484EOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O45:K1 Deoxycytidine triphosphate deaminase (dcd) CSB-YP483485EOK
CSB-EP483485EOK
CSB-BP483485EOK
CSB-MP483485EOK
CSB-EP483485EOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O45:K1 Hydroxyethylthiazole kinase (thiM) CSB-YP483486EOK
CSB-EP483486EOK
CSB-BP483486EOK
CSB-MP483486EOK
CSB-EP483486EOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O45:K1 Glycine--tRNA ligase beta subunit (glyS) CSB-YP483487EOK
CSB-EP483487EOK
CSB-BP483487EOK
CSB-MP483487EOK
CSB-EP483487EOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O45:K1 Citrate lyase acyl carrier protein (citD) CSB-YP483488EOK
CSB-EP483488EOK
CSB-BP483488EOK
CSB-MP483488EOK
CSB-EP483488EOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O45:K1 Elongation factor P-like protein (yeiP) CSB-YP483489EOK
CSB-EP483489EOK
CSB-BP483489EOK
CSB-MP483489EOK
CSB-EP483489EOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O45:K1 Probable malate:quinone oxidoreductase (mqo) CSB-YP483490EOK
CSB-EP483490EOK
CSB-BP483490EOK
CSB-MP483490EOK
CSB-EP483490EOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O45:K1 Deoxyuridine 5'-triphosphate nucleotidohydrolase (dut) CSB-YP483491EOK
CSB-EP483491EOK
CSB-BP483491EOK
CSB-MP483491EOK
CSB-EP483491EOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O45:K1 Octanoyltransferase (lipB) CSB-YP483492EOK
CSB-EP483492EOK
CSB-BP483492EOK
CSB-MP483492EOK
CSB-EP483492EOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O45:K1 Pyrimidine-specific ribonucleoside hydrolase RihA (rihA) CSB-YP483493EOK
CSB-EP483493EOK
CSB-BP483493EOK
CSB-MP483493EOK
CSB-EP483493EOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O45:K1 Potassium-transporting ATPase A chain (kdpA), partial CSB-YP483494EOK
CSB-EP483494EOK
CSB-BP483494EOK
CSB-MP483494EOK
CSB-EP483494EOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O45:K1 Nucleoside triphosphatase nudI (nudI) CSB-YP483495EOK
CSB-EP483495EOK
CSB-BP483495EOK
CSB-MP483495EOK
CSB-EP483495EOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Escherichia coli O45:K1 Undecaprenyl phosphate-alpha-4-amino-4-deoxy-L-arabinose arabinosyl transferase (arnT), partial CSB-YP483496EOK
CSB-EP483496EOK
CSB-BP483496EOK
CSB-MP483496EOK
CSB-EP483496EOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務(wù),您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×